Lawyers in Germany

Frank Steinbach

Partner – German and European Patent Attorney

Zimmermann & Partner Patentanwälte mbB

Frank Tepper-Sawicki

Frank Tepper-Sawicki, EMBA, is a Partner in the Corporate practice of Dentons' Düsseldorf and Munich offices. He advises German and international clients on corporate law/mergers and acquisitions. He focuses on advising national and international companies and investors on M&A transactions, corporate restructuring and reorganization. His clients include private equity and venture capital investors as well as (multi-)national companies and emerging growth companies. His work focuses on advising companies and investors in the field of technology and regulated industries (energy). He advises, for instance, companies in the IT industry as well as in the biotechnology and automotive sectors, and also advises groups and emerging growth companies on the implementation of innovative digital business models (including the use of artificial intelligence and blockchain technology).

Dentons

Frank Wegmann

Partner | Lawyer Competences: Defense of claims against investors; Defense of claims against professionals; Specialist in complex mass disputes; Litigation in insolvency law

LUTZ | ABEL RECHTSANWALTS PARTG MBB

Franziska Huber

Dr Franziska Huber is a Senior Associate in Fieldfisher´s Munich office and advises on all regulatory issues in the Life Science sector. Our clients include national and international companies. Her particular focus is on advising pharmaceutical companies and manufacturers of medical devices on regulatory matters. She also provides support in the negotiation and drafting of various types of contracts in the Life Sciences sector. In addition, as part of the Life Science Regulatory Practice Group at Fieldfisher, she advises on market access, particularly with regard to reimbursement and pricing of medicinal products and medical devices in the inpatient and outpatient service sector of the SHI, including method assessment procedures before the G-BA as well as negotiations with statutory health insurance funds and the SHI-SV. The regulatory advisory practice includes in particular the placing on the market of medicinal products and medical devices (conformity assessment procedures, marketing authorisation, distribution, GDP, contracts between actors in the supply chain), wholesale authorisations, compassionate use and single importation, clinical trials and good manufacturing practice.

Fieldfisher

Franziska von der Decken

Senior Associate

HOYNG ROKH MONEGIER

Frederic Geber

Partner

POSSER SPIETH WOLFERS & PARTNERS

Frederik Karl

Associate

HOYNG ROKH MONEGIER

Frederik Lorenzen

Frederik specialises in international asset, project and acquisition finance, corporate loans and leasing as well as restructuring transactions. His clients include banks and financial institutions and borrowers as well as lessees and lessors. He is recommended for his expertise by legal directory IFLR 1000.

Watson Farley & Williams LLP

Frederik Mühl

Frederik Mühl is a private equity and infrastructure M&A partner in the Corporate Department of Paul Hastings and is based in the firm’s Frankfurt office. He specializes in representing private equity and infrastructure investors on national and cross-border corporate transactions. In addition to his buy-out and infrastructure practice, Mr. Mühl has considerable experience with growth transactions and has advised on a number of distressed M&A transactions.

Paul Hastings LLP

Frederik Winter

Linklaters

Friedemann Eberspächer

Partner

Raue

Friedhelm Unverdorben

Partner

Raue

Friedrich Schlott

Friedrich Schlott is a restructuring partner in the Frankfurt office of Kirkland & Ellis International LLP. Friedrich has longstanding experience in restructuring, insolvency-related corporate law and insolvency law. He focuses on both in-court and out-of-court restructurings and advises companies, directors and stakeholders across the capital structure on all types of insolvency and restructuring-related (cross-border) aspects of debt and equity transactions.

Kirkland & Ellis International LLP

Friedrich Tobias Schöne

Partner

Raue

Friedrich von der Heydt-von Kalckreuth

Friedrich von der Heydt is a corporate partner in the Frankfurt office of Kirkland & Ellis International LLP. He advises corporations, financial institutions and financial sponsors on all aspects of corporate law, with a strong focus on M&A transactions in the infrastructure space.

Kirkland & Ellis International LLP

Fritz Lahrtz

Fritz is a European and German Patent attorney. He represents his clients in all fields of intellectual property with an emphasis on patent prosecution and opposition, nullity and infringement proceedings. Specifically, in recent years, he has gained extensive experience in multinational infringement proceedings, where he represents his clients before the German Federal Patent Court, the German infringement courts as well as before the opposition divisions and appeal boards of the European Patent Office. Since he is also responsible for establishing and coordinating the patent strategy of large patent portfolios, he has developed a deep insight into all aspects of patent prosecution. This includes also the provision of validity and infringement opinions. His clients include start-up companies, universities as well as large multinational companies. Due to his scientific education in the fields of immunology and neurobiology, he primarily works in the technical fields of biotechnology, chemistry and pharma, with an emphasis on handling antibody-related cases.

Simmons & Simmons

Gabriele Engels

Partnerin Rechtsanwältin

D Young & Co LLP

Gabriele Haas

Dr. Gabriele Haas is a partner in Dentons’ Frankfurt office and a member of the Corporate / M&A practice group. Gabriele leverages her extensive in-house experience as an executive in the energy sector, advising on energy law, regulatory law and compliance. Within her energy and regulatory practice, her main area of focus is energy transition issues, such as decarbonization, sector coupling, energy storage and advising on the regulation of hydrogen, green gas, clean and low emission fuels, e-mobility, emissions reduction and emissions trading as well as the wholesale energy market and its regulation. In addition to her energy and regulatory practice, she advises clients on current compliance and ESG issues, such as the EU Taxonomy Regulation, the Supply Chain Duty of Care Act and the implementation of preventive measures for sustainable corporate governance, among others. She also advises on the development of customized compliance management systems, organizational structures and procedures, as well as on the risks of fines and civil liability. She further advises on the prevention of market manipulation and insider trading, bribery and corruption, money laundering and terrorist financing as well as violations of human rights.

Dentons

Georg Andreas Rauh

PARTNER, Rechtsanwalt (Attorney-at-Law), UPC Representative His professional practice is focused on advising leading national and international clients in complex patent disputes before the German infringement and nullity courts as well as the European and German Patent offices in all technical fields, with a specific focus on telecoms/consumer electronics, biotech, med-tech and pharma litigation. Dr. Rauh has been lead counsel in multiple international patent disputes and thus possesses a profound expertise in international patent law as well as the coordination of multi-national patent infringement proceedings. He is also a renowned expert in anti-trust issues surrounding IP law, in particular with regard to the FRAND defense in standard essential patent cases. Dr. Rauh studied law at the Ludwig-Maximilians-University in Munich. During his studies and at the beginning of his career, he worked for several renowned IP law firms in Munich, Madrid, Buenos Aires and California. He finished his doctoral thesis on the topic of “Indirect (Contributory) Patent Infringement in Germany, Japan and the US” (summa cum laude, faculty price of the University of Munich) under the supervision of Prof. Dr. Dr. h.c. Joseph Straus at the Max-Planck-Institute of Innovation and Competition, which has been published in the institute’s famous series on Intellectual Property Law as volume 161. Dr. Rauh is author of multiple publications and regularly lectures on actual topics of German and European patent law. He speaks German and Spanish as a mother tongue, as well as English. Dr. Rauh is regularly mentioned as a highly recommended litigator in leading legal rankings for Germany/Europe.

Vossius & Partner

Georg Linde

Georg Linde is a partner in the Corporate & Financial Services Department. He focuses on complex corporate/M&A and private equity transactions. Georg has a particular focus in high-tech sectors including aerospace, IT/telecommunications, chemicals and renewable energies.

Willkie Farr & Gallagher LLP

Georg Miggel

Partner

Raue

Georg Weidenbach

Georg Weidenbach is a partner in Willkie’s Antitrust & Competition Department and Litigation Department and Co-Chair of the European Antitrust & Merger Control Practice Group. He is based in the Firm’s Frankfurt office. Georg focuses on European and German antitrust law. He advises clients on complex merger control cases, cartel investigations and related cartel damage claims, compliance programs and audits, antitrust related distribution and abuse of dominance matters.

Willkie Farr & Gallagher LLP

Georg von Wallis

Partner/Shareholder

Greenberg Traurig Germany

George Hacket

George Hacket currently heads the equity capital markets practice and the U.S. securities team in the Clifford Chance Frankfurt office, specializing in cross-border debt and equity transactions and advising issuers and underwriters on legal aspects of international securities offerings. George advises on IPOs, capital increases, stock exchange listings and high yield and investment grade debt issuances. George also has experience in advising on corporate governance and compliance matters for listed companies. He has further gained experience in a number of industries, including industrials and mobility, energy, infrastructure and healthcare and life sciences.

Clifford Chance